Plant food supplements (PFS) are products of increasing popularity and wide-spread distribution. Nevertheless, information about their risks is limited. To fill this gap, a poisons centres-based study was performed as part of the EU project PlantLIBRA. Multicentre retrospective review of data from selected European and Brazilian poisons centres, involving human cases of adverse effects due to plants consumed as food or as ingredients of food supplements recorded between 2006 and 2010. Ten poisons centres provided a total of 75 cases. In 57 cases (76%) a PFS was involved; in 18 (24%) a plant was ingested as food. The 10 most frequently reported plants were Valeriana officinalis, Camellia sinensis, Paullinia cupana, Melissa officinalis, Passiflora incarnata, Mentha piperita, Glycyrrhiza glabra, Ilex paraguariensis, Panax ginseng, and Citrus aurantium. The most frequently observed clinical effects were neurotoxicity and gastro-intestinal symptoms. Most cases showed a benign clinical course; however, five cases were severe. PFS-related adverse effects seem to be relatively infrequent issues for poisons centres. Most cases showed mild symptoms. Nevertheless, the occurrence of some severe adverse effects and the increasing popularity of PFS require continuous active surveillance, and further research is warranted.
INTRODUCTION
In the last two decades, the use of dietary supplements has increased dramatically all over the world. Changes in the legislation of medications and related products lead to an expansion of the markets for dietary supplements and allowed more intensive marketing (Denham, 2011; Miroddi et al., 2013; Silano et al., 2011; VargasMurga et al., 2011) , resulting in a growing awareness and information of the population about health aspects. The rising significance of health issues in daily life, together with an increased possibility and tendency to self-medicate, and the aging of the population seem to be the major reasons for the success of the dietary supplements (Kennedy, 2005; Peters et al., 2003) . Additional factors that promote the consumption of products of plant origin include the belief that botanicals are natural and therefore safe and the mistrust in conventional medications (Egan et al., 2011; Lynch and Berry, 2007; Marinac et al., 2007) .
Food supplements with botanical ingredients, also called plant food supplements (PFS), cover a broad field of indications, and therefore a wide range of plants are involved. Some preparations contain only one ingredient, which can consist of an extract (or concentrate) of a single plant or a specific plant compound (e.g. caffeine). Other PFS are a combination of several plants. In case of adverse effects, the complex nature of these ingredients and products makes it difficult to identify the causative component.
Along with the global spreading and the increasing use of PFS, scientific research on these products was intensified. However, clinical data on adverse effects of PFS are scarce and the literature mainly consists of case reports or case series on single plants (Di Lorenzo et al., 2015) . The issue of underreporting is particularly relevant in this area and partially explains paucity of data on adverse effects to these products (Geller et al., 2015; Kennedy, 2005) .
The occurrence of some severe incidents after the intake of PFS (Palmer et al., 2003; Vassilev et al., 2009; Vitalone et al., 2011) demonstrated the need for additional studies on PFS-related adverse effects. For these reasons, the European Community's Seventh Framework Programme funded PlantLIBRA project (www. plantlibra.eu) also comprised research on the adverse effects profile of PFS and plants consumed as food (Bucchini et al., 2011) .
The aim of this study was to identify plants commonly involved in adverse reactions related to the intake of PFS and of plants consumed as food, and to describe the type and severity of associated signs and symptoms by analysing data collected by poisons centres.
METHODS
Study design. Through a multicentre retrospective review of data from European and Brazilian poisons centres, documented human adult and pediatric cases (children defined as ≤16 years) of adverse effects related to the intake of PFS or plants consumed as food were collected for the period 2006 -2010. The inclusion of Brazil in a European study is due to the fact that the University of San Paulo was one of the extra-European PlantLIBRA partners, as required by the specific project call.
Inclusion and exclusion criteria. The following criteria had to be met for reported cases to be included in the study:
• Exposure to an agent categorized as PFS by the reporting poisons centre or exposure to a plant listed in an annex of the study protocol (the plant list can be accessed online as supplementary data, (WHO, 2015) and included an adequate temporal relationship between exposure and symptoms, absence of other exposures, or underlying diseases that can also explain the symptoms, and the presence of symptoms which are described for the substance in question or are plausible from a toxicodynamic point of view.
Exclusion criteria were:
• Asymptomatic exposures;
• Ingestion of the PFS/plant for other reasons than for nutrition or for a health benefit (e.g. child ingesting a plant accidentally; misidentification of plants);
• Ingestion of a plant (as food), that is not on the list;
• Ingestion outside the study period.
Each case was reviewed in detail and independently assessed by an expert panel at the Swiss National Poisons Centre, Tox Info Suisse, consisting of a pharmacist with expertise in plants, and a senior clinical pharmacologist and toxicologist with additional qualifications in general internal medicine. Any disagreement in case assessment was resolved by consensus.
Data collection and study population. Poisons centres were identified and contacted using the EAPCCT network (European Association of Poisons Centres and Clinical Toxicologists). The poisons centres were required to provide anonymized data-including age, sex, and weight of the patient, ingested substance and, if available, dose, type of symptoms/signs, laboratory values and causal relationship, severity of symptoms, and signs (graded according to the Poisoning Severity Score, PSS (Persson et al., 1998) ), therapeutic interventions and, if applicable, decontamination procedures performed with time between ingestion and decontamination-in a standardized exchange spreadsheet format. Data had to be translated into English; however Italian, Spanish, French, and German were also accepted due to language competencies within the Swiss National Poisons Centre.
Sixty-six requests for participation in the study were sent to European and Brazilian poisons centres. Of the 41 (62%) poisons centres who answered, 10 were able to provide a total of 426 cases. A total of 351 (82%) of these had to be excluded because they did not meet the inclusion criteria (i.e. insufficient causal relationship between ingested plant/PFS and observed symptoms and signs, asymptomatic ingestion, product not a PFS or plant not on the list, wrong circumstances of ingestion (e.g. child ingesting a plant accidentally), year of occurrence not within the study period, leaving 75 (18%) cases of adverse effects which were available for analysis.
Data processing and analysis. Since not all centres classify the severity of signs and symptoms in the same way, the cases were re-evaluated according to the Poisoning Severity Score (PSS) developed by the European Association of Poisons Centres and Clinical Toxicologists, the International Programme on Chemical Safety, and the European Commission (Persson et al., 1998) . The severity of symptoms of individual patients was classified as 'minor' if only mild, transient, and spontaneously resolving symptoms/signs were present, as 'moderate' if at least one pronounced or prolonged symptom/sign was recorded, as 'severe' if at least one severe or life-threatening symptom/sign was observed, or as 'fatal', if the ingestion of the PFS or plant was the recorded cause of death.
Data from the centres were merged into one single standardized Excel spreadsheet (Microsoft Excel 2010, Microsoft Corporation, Redmond, USA) and categorized into age groups, type of product, organ system involved, and severity of symptoms and signs. For the analyses of the relationships between PFS/plants and symptoms/signs, data were exported into an Access database (Microsoft Access 2010, Microsoft Corporation, Redmond, USA). Descriptive statistics were used to analyse grouped data.
Ethical approval. No ethics approval was required for this study according to a statement of the cantonal ethics committee Zurich. Each of the participating poisons centres was required to investigate whether or not a local ethics committee/institutional review board approval was required. The answers, and if applicable the local ethics committee approval, were transmitted to the Swiss National Poisons Centre, Tox Info Suisse. The procedure was surveyed by the ethics advisor of the PlantLIBRA project.
Data protection issues. Analyses were performed with completely anonymized data. Information was accessed and handled by study members only.
RESULTS

Patient characteristics and severity of signs and symptoms
The 75 cases included in the study originated from all over Europe (Finland 9 cases, France 31, Germany 4, Italy 13, Serbia 4, Sweden 5, Switzerland 5) and Brazil (4). Demographic characteristics of the patients were as follows: 68 adults (91%) with a mean age of 41.7 years (SD 18.8, median 40.0, range 16-92; age unknown in six cases) and seven children (9%) with a mean age of 11.4 years (SD 5.4, median 15, range 2-15). Both genders were almost equally represented among adults and children, in total there were 41 females (55%) and 34 males (45%).
Most cases showed a benign clinical course (Table 1) . Children mainly developed minor signs and symptoms, and there were no severe cases among this age group. Adults older than 65 showed a tendency towards more moderate and severe clinical courses compared to younger patients. No fatal outcome was observed.
Involved plants/PFS and severity of signs and symptoms
In 57 cases (76%) a PFS was involved, and in 18 (24%) a plant was ingested as food (Table 1 ). The number of involved PFS containing only one ingredient ('PFS mono') was comparable to that with more than one ingredient ('PFS multi'). PFS with more than one ingredient were more frequently associated with moderate and severe clinical courses (33.3%) compared to PFS with only one ingredient (10.0%).
Plants, as ingredients of PFS or consumed as food, involved in three or more cases are listed in Table 2 . Plants most commonly ingested as PFS were Valeriana officinalis L., Camellia sinensis (L.) Kuntze, Paullinia cupana Kunth, Melissa officinalis L., and Mentha piperita L.; plants most commonly consumed as food were Glycyrrhiza glabra L., Cynara scolymus L., Allium ursinum L., and Taraxacum officinale L.. The severity of signs and symptoms in relation to all plants involved in the cases of adverse effects due to the ingestion of a PFS or a plant consumed as food is shown in Table 3 .
Organ systems involved and observed signs and symptoms
General evaluation. In 59 (79%) of the 75 patients only one organ/organ system was involved; 14 patients had two organs/systems involved, and two patients had more than two organs/systems involved. The most frequently involved organ system was the nervous system (n = 34), followed by the gastrointestinal system (n = 27), the cardiovascular system (n = 13), skin/mucosa (n = 8), the liver (n = 4), the respiratory system (n = 2), the kidney (n = 1), and other organ systems (n = 5). Thirty-five patients showed one symptom, 27 patients two symptoms, 10 patients three symptoms, two patients four symptoms, and one patient five symptoms. All signs and symptoms observed in the patients are listed in Table 4 .
Analysis for individual plants. An overview of the reported signs and symptoms in relation to the plants involved in all cases of ingestion of PFS or plants consumed as food can be accessed online as supplementary data (Table B) .
Severe cases
There were five severe cases (Table 5 ); in three of these, a multi-ingredient PFS was involved. In a 72-year-old patient consuming G. glabra L. and M. piperita L. as an infusion in a high dose, a hypertensive crisis and severe hypokalemia were observed. In another case, a 30-year-old man was using a product containing Citrus aurantium L., C. sinensis (L.) Kuntze, P. cupana Kunth, and Coleus forskohlii (Willd.) Briq., which he combined with a product containing Rhodiola rosea L. to lose weight. He had a weight loss of 18 kg in two months and suffered a myocardial infarction during sexual 
DISCUSSION
In this study, adverse effects due to the ingestion of PFS or plants consumed as food seem to be infrequent issues for poisons centres; a finding that is supported by other studies. An analysis of calls involving the ingestion of a single medication reported to a poisons centre revealed that 3.4% were related to adverse drug reactions and of these only 4.7% were caused by the group of dietary supplements/herbals/homeopathics (Vassilev et al., 2009) . In a prospective poisons centre study, only 0.4% of the calls concerned dietary supplements, of which 33% were due to adverse effects (Haller et al., 2008) . Since the consumption of dietary supplements is widespread, it is plausible that adverse effects occur regularly, as has been recently shown by Geller et al. (2015) , but are probably detected only to a small extent by poisons centres or physicians. People not thinking of poisons centres as information source or not reporting their use of dietary supplements to the physician might explain these observations; this has been confirmed by other studies (Kennedy, 2005; Wu et al., 2011) . A study investigating the safety of phytomedicines (Cuzzolin et al., 2006) found that about half of the interviewed women attending an urban university hospital were consuming a PFS and 10% of them reported adverse effects. In 62% the adverse effects were not communicated to the doctor. In addition, consumers might not be aware that they are suffering from adverse effects due to herbal supplements. This study analysed two situations in which plant material was ingested: on the one hand the ingestion of a plant in form of a preparation (PFS) with the purpose to maintain health, and on the other, the consumption of a plant as food. Between these two situations there were considerable differences concerning the involved plants and, accordingly, the observed signs and symptoms. Consumption of plants as food mainly involved a single plant and caused gastrointestinal symptoms, allergic reactions, and electrolyte changes, whereas the ingestion of PFS involved many different symptoms due to the large diversity of plants and the concurrent ingestion of multiple plants. Although the two situations differ considerably, information about symptoms related to the ingestion of a single plant as food might give an indication about the possible toxicity of a PFS containing the same plant.
In this study gastrointestinal and neurological symptoms were the clinical effects most frequently observed, which is in accordance with data from the Italian pharmacovigilance centre on spontaneously reported adverse effects related to natural health products (including homeopathics) (Menniti-Ippolito et al., 2008) . Data on complementary medicines from pharmacovigilance centres in Sweden and Singapore showed different results. In the Singapore database mostly endocrine and nervous system disorders were recorded (Patel et al., 2012) , whereas in Sweden skin and hypersensitivity reactions predominated (Jacobsson et al., 2009) . Part of these differences can be explained by the type of institution which performed the study: pharmacovigilance centres focus on adverse reactions to drugs ingested in therapeutic doses, whereas poisons centres mostly deal with overdoses of drugs and other substances. The fact that skin reactions predominated among the adverse effects to natural health products in the Swedish study is in line with data from the WHO adverse drug reactions database, where skin reactions were the most frequently registered symptoms associated with the use of herbal medicines Common dandelion 2 1 3 (Farah et al., 2000) . In the Singapore study, many cases of adulteration (with pharmaceutical substances) were reported and the involved substances rather than the plants were responsible for the adverse effects (e.g. endocrine disorders). The quality of the involved plant material is a general issue when it comes to the use of PFS. Lack of standardization and contamination with other plants during preparation, together with no or poor quality control, may lead to adverse effects in case of consumption (Soares Neto et al., 2013) and could have also contributed to the adverse effects observed in our study. Hepatotoxicity is an important issue when investigating the safety of medications, and many herbal medications do affect the liver (Bunchorntavakul and Reddy, 2013; Stickel et al., 2005; Teschke et al., 2012) . Nevertheless, in this study there were only few reports of hepatotoxicity (4 of 75 cases), and this is in contrast to the literature. The plants associated with hepatic signs and symptoms in this study included Angelica archangelica L., C. sinensis (L.) Kuntze, Carum carvi L., Crithmum maritimum L., Dioscorea villosa L., Fucus vesiculosus L., Glycine max (L.) Merr., Hibiscus sabdariffa L., M. piperita L., and Opuntia ficus-indica (L.) Mill.. Although reports and experimental studies on hepatotoxicity of C. sinensis (L.) Kuntze (Bunchorntavakul and Reddy, 2013; Mazzanti et al., 2009) , D. villosa L. (Wojcikowski et al., 2008) , and M. piperita L. (Akdogan et al., 2004) exist, the design of the present study does not allow to add further evidence, particularly if the plant was part of a multi-ingredient product. In addition, a causality assessment according to RUCAM (Roussel Uclaf Causality Assessment Method), which is the reference method for evaluating drug and herb induced liver injury (Danan and Teschke, 2016) , was not possible due to incomplete case information. This is for example the case for D. villosa L., which was involved in two of the four cases of hepatotoxicity. However, as the PFS included multiple ingredients and as some analytical data were missing, a definitive causal relationship could not be established. Nevertheless, this plant deserves particular attention, and further investigation is warranted.
ADVERSE EFFECTS OF PFS AND PLANTS CONSUMED AS FOOD
Most cases in this study showed mild symptoms and a benign clinical course, which is consistent with other studies from poisons centres evaluating adverse effects related to herbal remedies and dietary supplements (Haller et al., 2008; Yang et al., 2002) , where most adverse effects were mild and severe outcomes were rare. In contrast, the adverse effects described in the Italian pharmacovigilance study were associated with a rather high need for hospitalization (Menniti-Ippolito et al., 2008) , an observation they explain by a greater attention to complete drug history in patients with serious reactions. In our study, there seemed to be more severe courses when a multi-ingredient PFS or a plant consumed as food were involved, as compared to the ingestion of a single-ingredient PFS. The symptoms most commonly recorded in the moderate cases of this study were-apart from unspecific gastrointestinal symptoms -edema and hypokalemia, sometimes accompanied by hypertension or ECG changes. In all of these cases G. glabra L. was involved. These observations correspond well to the known effects of the plant, which affects the electrolyte balance (Isbrucker and Burdock, 2006; Olukoga and Donaldson, 2000) .
The plant most commonly involved in cases of adverse effects related to the ingestion of PFS or plants consumed as food was V. officinalis L.. The adverse reactions most frequently observed with this plant in this study, i.e. somnolence, drowsiness, and gastrointestinal symptoms, are also described in the literature (Taibi et al., 2007) , and the neurological symptoms are very well explained by valerian's properties as relaxant and sleep aid. Valerian was usually the only component of the PFS ingested. This suggests a probable causal relationship between the symptoms and the plant.
Products containing widely used plants for weight loss such as C. sinensis (L.) Kuntze, Ephedra distachya L., Hoodia gordonii (Masson) Sweet ex Decne., C. aurantium L., and Garcinia cambogia (Gaertn.) Desr. were only rarely recorded, although they are marketed as highly effective. Reasons for this observation might be the poor availability in shops due to legal restrictions based on their negative safety profile or the fear of serious side effects (i.e. cardiotoxicity), which are known for some of these plants (Vitalone et al., 2011) .
Some other plants reported to be most frequently used as supplements in the literature, including P. ginseng C.A.Mey., Echinacea sp., Ginkgo biloba L., Hypericum perforatum L., Allium sativum L., and Serenoa repens (W.Bartram) Small (Kennedy, 2005; Marinac et al., 2007; Wu et al., 2011) , were only rarely involved in the cases of this study. The same is true for plants contained in supplements enhancing athletic performance and aphrodisiacs (e.g. C. forskohlii (Willd.) Briq., Schisandra chinensis (Turcz.) Baill., Tribulus terrestris L., Pausinystalia yohimbe (K.Schum.) Pierre ex Beille, Epimedium grandiflorum C.Morren, Trigonella foenum-graecum L., L. meyenii Walp, T. diffusa Willd. ex Schult.) (Rowland and Tai, 2003) . This may be due to the fact that some products containing these plants are classified as pharmaceuticals and not as PFS and were therefore not included in the study. 
Limitations
The interpretation of the findings of this study is mainly limited by the retrospective nature of the study design with the related incompleteness of data and lack of uniform data classification. This is for example the case for the ingested dose of a PFS or a plant, which could not always be recorded or specified in detail. In addition, this is the reason why causality assessment of hepatotoxicity cases according to RUCAM (Danan and Teschke, 2016) was not possible. A further limitation is related to the object of the study and to the fact that there is a lack of uniform categorization of PFS among different countries. The legal status of a herbal preparation depends on the law of the specific country, meaning that a preparation can be classified as a supplement in one country, as a (traditional) medicinal product in another, and as a pharmaceutical in a third one (Egan et al., 2011; Silano et al., 2011) . Also the wide range of different terminology used for PFS, which are interchangeably referred to in the literature as 'plant foods', 'plant extracts', 'botanicals', 'herbals', and/or 'herbs' (Egan et al., 2011) adds to the complexity of the subject.
Furthermore, it is known from the literature that data from poisons centres are subject to reporting bias (Hoffman, 2007) , and it is plausible that delayed effects and chronic toxicity were underrepresented. It is also known that patients tend to underreport the use of PFS and the magnitude of their use is underrecognized by physicians (Cuzzolin et al., 2006; Kennedy, 2005; Wu et al., 2011) . In addition, our strict inclusion criteria led to small case numbers, especially for some PFS/plants. However, we are convinced that these restrictions were necessary to be able to interpret the findings properly. Due to the limited number of cases involving children, the results regarding this population should be interpreted with particular caution.
The fact that a large diversity of plants was involved in many documented cases with adverse effects is an important limitation regarding the risk assessment of single plants and the establishment of a causal relationship between a plant and an adverse effect.
CONCLUSIONS
PFS-related adverse effects seem to be relatively infrequent issues for poisons centres and most cases in this study showed mild symptoms and a benign clinical course. Nevertheless, the occurrence of some severe adverse effects and the increasing popularity of PFS together with the issue of underreporting require continuous active surveillance, especially of possible vulnerable groups such as the elderly. Further research is warranted to validate the preliminary results of this study, and a multidisciplinary approach with an international perspective should be prioritized.
